Insider · CIK 0001825445
Adam Crystal
officerpresident
Files at TNGX (Tango Therapeutics, Inc.). First filing Feb 6, 2025, latest Oct 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $2.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
TNGXOct 9, 2026 · close 23.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Tango Therapeutics, Inc. | $661k 27,000 shares | -19% | +254% from low-26% from high | |
| 9Weak | Tango Therapeutics, Inc. | $604k 27,000 shares | -19% | - | |
| 0Weak | Tango Therapeutics, Inc. | $241k 12,000 shares | -10% | +1798% from low0% from high | |
| 19Weak | Tango Therapeutics, Inc. | $304k 20,251 shares | -15% | +1430% from low0% from high | |
| 31Weak | Tango Therapeutics, Inc. | $694k 54,345 shares | -29% | +1048% from low-3% from high | |
| 48Moderate | Tango Therapeutics, Inc. | $226k 18,452 shares | -9% | +1041% from low-4% from high | |
| 36Weak | Tango Therapeutics, Inc. | $44k 14,283 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +27,000 | $5.20 | $140k | 142,743 | 8 d ago |
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -26,400 | $24.45 | $646k | 116,343 | 8 d ago |
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -600 | $25.32 | $15k | 115,743 | 8 d ago |
| Oct 1, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -27,000 | $0.00 | $0 | 233,040 | 8 d ago |
| Sep 1, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +27,000 | $5.20 | $140k | 142,743 | 40 d ago |
| Sep 1, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -27,000 | $22.37 | $604k | 115,743 | 40 d ago |
| Sep 1, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -27,000 | $0.00 | $0 | 260,040 | 40 d ago |
| Mar 25, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,000 | $5.20 | $62k | 124,622 | Mar 27, 2026 |
| Mar 25, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,000 | $20.11 | $241k | 112,622 | Mar 27, 2026 |
| Mar 25, 2026 | TNGX Tango Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 460,500 | Mar 27, 2026 |
| Mar 5, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,251 | $15.00 | $304k | 112,622 | Mar 9, 2026 |
| Feb 25, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -54,345 | $12.77 | $694k | 132,873 | Feb 27, 2026 |
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stock | +47,460 | $0.00 | $0 | 205,670 | Feb 4, 2026 |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -18,251 | $12.26 | $224k | 187,419 | Feb 4, 2026 |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -201 | $12.90 | $2,592 | 187,218 | Feb 4, 2026 |
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +284,760 | $0.00 | $0 | 284,760 | Feb 4, 2026 |
| Feb 4, 2025 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -7,432 | $2.99 | $22k | 165,061 | Feb 6, 2025 |
| Feb 5, 2025 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -6,851 | $3.16 | $22k | 158,210 | Feb 6, 2025 |
| Feb 3, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stock | +53,015 | $0.00 | $0 | 172,493 | Feb 5, 2025 |
| Feb 3, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +318,090 | $0.00 | $0 | 318,090 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.